Cayman Aica Ribonucleotide; Qty- 5; Size-5 Mg

AICA ribonucleotide is a cell-permeable activator of AMP-activated protein kinase (AMPK).¹ It activates AMPK in a cell-free assay when used at concentrations ranging from 1 to 500 µM. AICA ribonucleotide (100-500 µM) inhibits lipolysis and lipogenesis in primary rat adipocytes. In vivo, AICA ribonucleotide (0.5 mg/kg) increases insulin sensitivity and prevents pancreatic β-cell damage in Zucker diabetic fatty rats.² AICA ribonucleotide (0.5 mg/kg) induces cardiac mobilization and myofibroblast differentiation of endogenous CD44⁺CD45^- mesenchymal stem cells (MSCs), as well as decreases cardiac scar formation, in an aged mouse model of myocardial infarction induced by left anterior descending artery (LAD) occlusion.³ Formulations containing AICA ribonucleotide have been used in the treatment and prevention of cardiac ischemic injury.

WARNING This product is not for human or veterinary use.